Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods

Table 3 Insulin sensitivity indices in Group I

Time	0 mo (mean ± SE)	6 mo (mean ± SE)	12 mo	P value
FPI (uU/mL)	123 ± 91.87	75.83 ± 58.69		0.707
HOMA-IR%	11.72 ± 5.39	6.96 ± 1.32		0.368
HOMA-B%	146.26 ± 56.44	63.33 ± 13.99		0.183
Fasting C-peptide (ng/mL)	2.97 ± 1.51	2.94 ± 0.80		0.973
Stimulated C-peptide (ng/mL)	4.26 ± 1.59	4.23 ± 0.84		0.989

HOMA-IR: Homeostasis model assessment insulin resistance index; HOMA-B: Homeostasis model assessment beta cell function.